Fasciitis

National Advertising Division Refers Advertising Claims for Gravity Defyer Shoes to Federal Trade Commission for Possible Enforcement Action

Retrieved on: 
Tuesday, September 14, 2021

NEWYORK, Sept. 14, 2021 /PRNewswire/ --The National Advertising Division (NAD) of BBB National Programs is disappointed that Gravity Defyer Medical Technology Corporation declined to participate in the industry self-regulation process.

Key Points: 
  • NEWYORK, Sept. 14, 2021 /PRNewswire/ --The National Advertising Division (NAD) of BBB National Programs is disappointed that Gravity Defyer Medical Technology Corporation declined to participate in the industry self-regulation process.
  • As a result of the advertiser's failure to participate, NAD has referred advertising claims for their Gravity Defyer shoes to the Federal Trade Commission (FTC) for review.
  • In 2019, NAD requested that Gravity Defyer Medical Technology Corporation provide evidence that it complied with a 2011 NAD decision to discontinue certain health-related claims for Gravity Defyer shoes.
  • About the National Advertising Division:TheNational Advertising Division (NAD) of BBB National Programsprovidesindependent self-regulationand dispute resolution services,guidingthe truthfulness of advertising across the U.S. NADreviews national advertising in all media and its decisions set consistent standards foradvertisingtruth and accuracy, delivering meaningful protection toconsumersand leveling the playing field for business.

HeelAid First Brush-On Treatment to Relieve Plantar Fasciitis Pain in a Week Now With CBD

Retrieved on: 
Thursday, March 25, 2021

"Cannabidiol, known as CBD, represents the biggest breakthrough in non-opioid pain relief in decades," continued Dr. Burke.

Key Points: 
  • "Cannabidiol, known as CBD, represents the biggest breakthrough in non-opioid pain relief in decades," continued Dr. Burke.
  • "We added CBD to the already impressive HeelAid formulation and have seen how the plantar fascia responds exquisitely to this safe, natural, pain relieving substance."
  • Based on ongoing clinical trials and patient data, pain relief usually occurs within a week for 3 out of 4 patients.
  • ABOUT HEELAID and BRIANT BURKE MD, MS
    HeelAid is the first brush-on natural, topical agent to provide pain relief within a week for the symptoms of plantar fasciitis.

Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

Retrieved on: 
Tuesday, March 16, 2021

Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos

Key Points: 
  • "Women who chronically wear high heels are prone to a variety of foot problems, including pain, bunions, hammer toe and Plantar fasciitis.
  • "Luxury Feet can be a life-changing product as we transition back to our pre-COVID lives," commented Nina Goldstein, Marketing Manager of Nutra Pharma.
  • "To all the ladies out there who feel the pain after a day in heels, especially after not wearing high heels during quarantine; relief is just around the corner," she continued.
  • Luxury Feet is an over-the-counter (OTC) homeopathic pain reliever that relies on natural cobra venom's ability to alleviate pain and inflammation.

MiMedx Concludes Enrollment for Phase 3 Plantar Fasciitis Trial

Retrieved on: 
Thursday, September 17, 2020

"Plantar fasciitis is an all-too-common, debilitating and painful foot condition that challenges both patients and clinicians.

Key Points: 
  • "Plantar fasciitis is an all-too-common, debilitating and painful foot condition that challenges both patients and clinicians.
  • Our progress to date is all the more gratifying given the dampening effect of the pandemic on patient enrollment.
  • More than two million people are treated for plantar fasciitis inflammation in the United States annually.
  • This study is a Phase 3, prospective, double-blinded, randomized controlled trial of the micronized dehydrated Human Amnion Chorion Membrane (dHACM) injection as compared to saline placebo injection in the treatment of plantar fasciitis.

Globl Plantar Fasciitis Treatment Market Industry Analysis - Size, Share, Growth, Trends and Forecasts to 2027

Retrieved on: 
Wednesday, February 12, 2020

DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Plantar Fasciitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Plantar Fasciitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • The report also provides detailed information regarding how the plantar fasciitis treatment market will accelerate and underpin momentum during the foreseeable period (2019-2027).
  • The report offers incisive dynamics about the various aspects and nuances of the plantar fasciitis treatment market, to assist market players in making winning strategies.
  • What rate of ROI can plantar fasciitis treatment market players expect from its oral treatment in the next couple of years?

Plantar Fasciitis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Retrieved on: 
Wednesday, September 25, 2019

The report offers incisive dynamics about the various aspects and nuances of the plantar fasciitis treatment market, to assist market players in making winning strategies.This report also offers information about the vital changes that are anticipated to shape the plantar fasciitis treatment market during the projection period.

Key Points: 
  • The report offers incisive dynamics about the various aspects and nuances of the plantar fasciitis treatment market, to assist market players in making winning strategies.This report also offers information about the vital changes that are anticipated to shape the plantar fasciitis treatment market during the projection period.
  • The report covers an exhaustive taxonomy of the plantar fasciitis treatment market and riveting insights on the competitive landscape.
  • This research study gauges the plantar fasciitis treatment market based on type, end user, and region.
  • What rate of ROI can plantar fasciitis treatment market players expect from its oral treatment in the next couple of years?

New Foot Ease, The First Supplement for Plantar Fasciitis Relief

Retrieved on: 
Thursday, August 30, 2018

MELBOURNE, Fla., Aug. 30, 2018 /PRNewswire/ --One in 10 people suffer from the debilitating effects of Plantar Fasciitis at least once in their lives.

Key Points: 
  • MELBOURNE, Fla., Aug. 30, 2018 /PRNewswire/ --One in 10 people suffer from the debilitating effects of Plantar Fasciitis at least once in their lives.
  • Vitagolife.com has now released FOOT EASE, a supplement that is helping to heal painful Plantar Fasciitis.
  • The company owner, Michael Brunett, suffered from the symptoms of Plantar Fasciitis & Achilles Tendinitis for over 10 years.
  • Foot Ease is designed to give the body the necessary nutrients that the feet need to function properly and to stay healthy.